cefuroxime has been researched along with Staphylococcal Pneumonia in 2 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vitkauskiene, A | 1 |
| Sakalauskas, R | 1 |
| Dudzevicius, V | 1 |
| Svenungsson, B | 1 |
| Kalin, M | 1 |
| Lindgren, LG | 1 |
2 other studies available for cefuroxime and Staphylococcal Pneumonia
| Article | Year |
|---|---|
[The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective | 2003 |
Therapeutic failure in pneumonia caused by a tolerant strain of Staphylococcus aureus.
Topics: Adult; Cefuroxime; Cloxacillin; Female; Gentamicins; Humans; Influenza, Human; Penicillin G; Penicil | 1982 |